Sphenolax®
Strongly activates TGR5. Weak GLP1 receptor agonism. Strongly inhibits DYRK1A. Hypoglycemic overall effect on prolonged usage.
NGN 65,000.00
Metabolic syndrome
Nubeta 500mg Capsule
NGN 75,000.00
Upgregulation of UCP-1 in the white adipose tissue resulting in weight loss. Depletes stored fat. Promotes satiety, improves caloric utilisation and gut health. Mitigates hypercholestrolemia. Improves cardiovascular health.
Additional Details
No exercise or dietry restriction required
Quantity:
1
